title: Rationale for growth hormone therapy in children with chronic kidney disease.
abstract: Growth retardation is a common complication in children with chronic kidney disease. Treatable causes of growth retardation in these patients include renal osteodystrophy, metabolic acidosis, and inadequate nutritional intake. In addition, disturbances in the growth hormone-insulinlike growth factor I axis are a major cause of decreased growth. Administration of recombinant human growth hormone can overcome this problem, allowing catch-up growth and achievement of normal or improved adult height.
authors.affiliation: Medical College of Wisconsin, Department of Pediatrics, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA. Lgreen@mcw.edu
authors.forename: Larry A
authors.initials: LA
authors.lastname: Greenbaum
authors.forename: Marcela
authors.initials: M
authors.lastname: Del Rio
authors.forename: Fatai
authors.initials: F
authors.lastname: Bamgbola
authors.forename: Frederick
authors.initials: F
authors.lastname: Kaskel
mesh_terms: D000293:Adolescent; D000818:Animals; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D006130:Growth Disorders / Q000188:drug therapy* / Q000209:etiology*; D013006:Growth Hormone / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007674:Kidney Diseases / Q000150:complications*
chemical_list: D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone